Sort   by:  
 Page size 
UnknownNovel Experimental Drugs for Treatment of Multiple Myeloma.
Not available
S-EPMC7955760 | biostudies-literature
UnknownBelantamab Mafodotin for the Treatment of Multiple Myeloma: An Overview of the Clinical Efficacy and Safety.
Not available
S-EPMC8180291 | biostudies-literature
UnknownAn evidence-based review of ixazomib citrate and its potential in the treatment of newly diagnosed multiple myeloma.
Not available
S-EPMC4189713 | biostudies-literature
UnknownCurrent Main Topics in Multiple Myeloma.
Not available
S-EPMC10136770 | biostudies-literature
UnknownBelantamab Mafodotin: From Clinical Trials Data to Real-Life Experiences.
Not available
S-EPMC10251850 | biostudies-literature
UnknownNovel Immunotherapies and Combinations: The Future Landscape of Multiple Myeloma Treatment.
Not available
S-EPMC10675193 | biostudies-literature
UnknownMonoclonal Antibodies: Leading Actors in the Relapsed/Refractory Multiple Myeloma Treatment.
Not available
S-EPMC7760536 | biostudies-literature
UnknownDaratumumab for the Management of Newly Diagnosed and Relapsed/Refractory Multiple Myeloma: Current and Emerging Treatments.
Not available
S-EPMC7928404 | biostudies-literature
UnknownEfficacy and tolerability of bendamustine, bortezomib and dexamethasone in patients with relapsed-refractory multiple myeloma: a phase II study.
Not available
S-EPMC3880441 | biostudies-literature
UnknownBelantamab mafodotin in triple-refractory multiple myeloma patients: A retro-prospective observational study in Italy.
Not available
S-EPMC11182418 | biostudies-literature
Sort   by:  
 Page size